Literature DB >> 8230435

Two E2 binding sites (E2BS) alone or one E2BS plus an A/T-rich region are minimal requirements for the replication of the human papillomavirus type 11 origin.

J Z Lu1, Y N Sun, R C Rose, W Bonnez, D J McCance.   

Abstract

Human papillomaviruses (HPVs) cannot be propagated in vitro, but the DNA can be replicated transiently in an assay in the presence of two trans-acting viral proteins, E1 and E2. Using this assay, we have defined the minimal cis-acting elements of the origin of replication of HPV type 11. Most HPV genomes are conserved at the origin of replication, and the core contains three E2 binding sites (E2BS) surrounding an A/T-rich spacer region. The present results show that the minimal requirement for replication is either two E2BS alone or the A/T-rich region plus one E2BS; in the latter case the relative position of the E2BS is important. In all the studies, the presence of both E1 and E2 proteins was essential for replication, yet only the E2BS was required at the origin. We have shown that E1, E2, and the origin of replication containing an E2BS from a complex in vitro, and our data are consistent with a model in which E2 acts to target E1 to the HPV type 11 replication origin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8230435      PMCID: PMC238175     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

Review 1.  DNA looping.

Authors:  R Schleif
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

2.  Activation of BPV-1 replication in vitro by the transcription factor E2.

Authors:  L Yang; R Li; I J Mohr; R Clark; M R Botchan
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

3.  The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase.

Authors:  L Yang; I Mohr; E Fouts; D A Lim; M Nohaile; M Botchan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

4.  The acidic transcriptional activation domains of VP16 and p53 bind the cellular replication protein A and stimulate in vitro BPV-1 DNA replication.

Authors:  R Li; M R Botchan
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

5.  A bovine papillomavirus E1-related protein binds specifically to bovine papillomavirus DNA.

Authors:  V G Wilson; J Ludes-Meyers
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

6.  Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins.

Authors:  C M Chiang; M Ustav; A Stenlund; T F Ho; T R Broker; L T Chow
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

7.  Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. OFF.

Authors:  S C Dollard; J L Wilson; L M Demeter; W Bonnez; R C Reichman; T R Broker; L T Chow
Journal:  Genes Dev       Date:  1992-07       Impact factor: 11.361

8.  Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles.

Authors:  R C Rose; W Bonnez; R C Reichman; R L Garcea
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

9.  Bovine papilloma virus (BPV)-encoded E2 protein enhances binding of E1 protein to the BPV replication origin.

Authors:  Y S Seo; F Müller; M Lusky; E Gibbs; H Y Kim; B Phillips; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

10.  Antibody-mediated neutralization of human papillomavirus type 11 (HPV-11) infection in the nude mouse: detection of HPV-11 mRNAs.

Authors:  W Bonnez; R C Rose; R C Reichman
Journal:  J Infect Dis       Date:  1992-02       Impact factor: 5.226

View more
  40 in total

1.  The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element.

Authors:  M J O'Connor; W Stünkel; C H Koh; H Zimmermann; H U Bernard
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 2.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

3.  mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication.

Authors:  Wentao Deng; Ge Jin; Biing-Yuan Lin; Brian A Van Tine; Thomas R Broker; Louise T Chow
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 4.  The E1 proteins.

Authors:  Monika Bergvall; Thomas Melendy; Jacques Archambault
Journal:  Virology       Date:  2013-09-10       Impact factor: 3.616

5.  Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.

Authors:  F Stubenrauch; A M Colbert; L A Laimins
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

6.  Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification.

Authors:  M A Ozbun; C Meyers
Journal:  Virology       Date:  1998-09-01       Impact factor: 3.616

7.  Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein.

Authors:  M G Frattini; L A Laimins
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

8.  Viral trans-factor independent replication of human papillomavirus genomes.

Authors:  Daraporn Pittayakhajonwut; Peter C Angeletti
Journal:  Virol J       Date:  2010-06-10       Impact factor: 4.099

9.  Thermodynamics of cooperative DNA recognition at a replication origin and transcription regulatory site.

Authors:  Mariano Dellarole; Ignacio E Sánchez; Gonzalo de Prat Gay
Journal:  Biochemistry       Date:  2010-11-10       Impact factor: 3.162

10.  Human papillomavirus DNA replication compartments in a transient DNA replication system.

Authors:  C S Swindle; N Zou; B A Van Tine; G M Shaw; J A Engler; L T Chow
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.